What's the difference between apheresis and patient?

Apheresis


Definition:

  • (n.) The dropping of a letter or syllable from the beginning of a word; e. g., cute for acute.
  • (n.) An operation by which any part is separated from the rest.

Example Sentences:

  • (1) Circulating numbers did not fall significantly during apheresis.
  • (2) Platelet concentrates collected by continuous flow automated apheresis (Fenwal CS-3000) were compared with those collected by manual apheresis to determine whether the prolonged centrifugation and vigorous resuspension affected platelet viability and in vitro function.
  • (3) Since exposure to blood products occurs on a daily basis during hemapheresis, the acquired immunodeficiency syndrome (AIDS) epidemic has a serious impact both for patients undergoing apheresis procedures as well as for health professionals working in the field.
  • (4) The incorporation of three sessions of apheresis, removing 90% of plasma and 30% of platelet population, into the conventional treatment schedule is shown to have an anticoagulant, thrombolytic and platelet hypersensitivity-controlling effect.
  • (5) The overall CE was calculated from the pre-apheresis cell counts and the stated blood volume processed.
  • (6) A blood sampling pack is available on closed system apheresis kits for the Fenwal CS3000 blood cell separator to facilitate same day donor testing while maintaining the closed system.
  • (7) Ethylene oxide gas, which was used to sterilize plastic components in the disposable apheresis kits, represented a possible source of sensitization.
  • (8) Peripheral stem cell apheresis and lymphocytapheresis are bringing patients with metastatic malignancies to the apheresis department with increasing frequency, and the apheresis staff must be alert to previously undescribed complications of apheresis.
  • (9) After transfusions which produced satisfactory responses, we identified the original whole blood donors to serve as apheresis donors.
  • (10) The COBE Spectra System will perform all types of apheresis procedures.
  • (11) Maintenance lipid apheresis administered 1 time per week resulted in a sustained reduction of total and LDL cholesterol and was associated with a sustained improvement in blood flow properties.
  • (12) Plateletpheresis was performed on 34 healthy donors (26 male and 8 female), formerly experienced by other apheresis procedures.
  • (13) HDL-cholesterol levels were somewhat raised, to a higher extent with dextran sulfate apheresis.
  • (14) A recent development of this procedure is LDL-apheresis, that is the selective removal of atherogenic LDL and the return to the patient of his own LDL-depleted plasma.
  • (15) A large animal model is needed to evaluate new apheresis technologies.
  • (16) The patient had received long-term LDL apheresis for 6 years and 7 months and had shown angiographic regression.
  • (17) These results suggested that LDL-apheresis using the dextran-sulphate cellulose column, may cause an increase in the turnover rate of the apo E-containing HDL and thus facilitate cholesterol removal from the peripheral tissues.
  • (18) Optimally adjusted anticoagulation under LDL apheresis is essential for successful treatment: Excessive anticoagulation exposes the outpatient to the risk of uncontrolled hemorrhage, insufficient anticoagulation may shorten the duration of utilization of the immune-adsorption columns.
  • (19) To assure that apheresis procedures are carried out in a safe, efficient and appropriate manner with minimum risk and maximum benefit.
  • (20) Low-density lipoprotein apheresis (LDL-apheresis) was done with either cascade filtration (DF) or dextran sulfate cellulose adsorption (DSC) in a patient with primary biliary cirrhosis who developed severe dyslipidemia associated with cholestasis and accumulation of lipoprotein-X (LP-X).

Patient


Definition:

  • (a.) Having the quality of enduring; physically able to suffer or bear.
  • (a.) Undergoing pains, trails, or the like, without murmuring or fretfulness; bearing up with equanimity against trouble; long-suffering.
  • (a.) Constant in pursuit or exertion; persevering; calmly diligent; as, patient endeavor.
  • (a.) Expectant with calmness, or without discontent; not hasty; not overeager; composed.
  • (a.) Forbearing; long-suffering.
  • (n.) ONe who, or that which, is passively affected; a passive recipient.
  • (n.) A person under medical or surgical treatment; -- correlative to physician or nurse.
  • (v. t.) To compose, to calm.

Example Sentences:

  • (1) Forty-nine patients (with 83 eyes showing signs of the disease) were followed up for between six months and 12 years.
  • (2) In studies of calcium metabolism in 13 unselected patients with untreated sarcoidosis all were normocalcaemic but five had hypercalcuria.
  • (3) Cancer patients showed abnormally high plasma free tryptophan levels.
  • (4) Previous use of the drug is found in more than 50 per cent of the patients, and it was often followed by a neglected side-effect.
  • (5) However, patients with GGBHS were significantly older (P less than .05).
  • (6) By presenting the case history of a man who successively developed facial and trigeminal neural dysfunction after Mohs chemosurgery of a PCSCC, this paper documents histologically the occurrence of such neural invasion, and illustrates the utility of gadolinium-enhanced magnetic resonance scanning in patient management.
  • (7) This excellent prognosis supports a regimen of conservative therapy for these patients.
  • (8) However, as other patients who lived at the periphery of the Valserine valley do not appear to be related to any patients living in the valley, and because there has been considerable immigration into the valley, a number of hypotheses to explain the distribution of the disease in the region remain possible.
  • (9) From 1982 to 1989, bronchoplasty or segmental bronchoplasty and pulmonary arterioplasty in combination with lobectomy and segmentectomy were performed for 9 patients with central type lung carcinoma.
  • (10) Thirty-two patients (10 male, 22 female; age 37-82 years) undergoing maintenance haemodialysis or haemofiltration were studied by means of Holter device capable of simultaneously analysing rhythm and ST-changes in three leads.
  • (11) It was shown that delta F508 frequency of CF-patients was 59.2%, the frequencies of S5491, G551D and K533X were about 1%.
  • (12) This study was undertaken to determine whether the survival of Hispanic patients with squamous cell carcinoma of the head and neck was different from that of Anglo-American patients.
  • (13) Combination therapy was most effective in patients receiving HCTZ prior to enalapril.
  • (14) Patients with papillary carcinoma with a good cell-mediated immune response occurred with much lower infiltration of the tumor boundary with lymphocyte whereas the follicular carcinoma less cell-mediated immunity was associated with dense lymphocytic infiltration, suggesting the biological relevance of lymphocytic infiltration may be different for the two histologic variants.
  • (15) Therefore, it is suggested that PE patients without endogenous erythroid colonies may follow almost the same clinical course as SP patients.
  • (16) In this study of ten consecutive patients sustaining molten metal injuries to the lower extremity who were treated with excision and grafting, treatment with compression Unna paste boot was compared with that with conventional dressing.
  • (17) Seventy patients were randomised to Fm 40 mg at night and Rn placebo and 62 to Rn 300 mg at night and Fm placebo.
  • (18) The rash presented either as a pityriasis rosea-like picture which appeared about three to six months after the onset of treatment in patients taking low doses, or alternatively, as lichenoid plaques which appeared three to six months after commencement of medication in patients taking high doses.
  • (19) Although the mean values for all hemodynamic variables between the two placebo periods were minimally changed, the differences in individual patients were striking.
  • (20) Patient plasma samples demonstrated evidence of marked complement activation, with 3-fold elevations of C3a desArg concentrations by the 8th day of therapy.